Myron Wentz
Founder chez USANA HEALTH SCIENCES, INC.
Fortune : 382 M $ au 31/03/2024
Postes actifs de Myron Wentz
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| USANA HEALTH SCIENCES, INC. | Director/Board Member | 01/05/2020 | - |
| Founder | 01/09/1992 | - | |
| Chief Executive Officer | 01/09/1992 | 23/07/2008 | |
| Chairman | 01/09/1992 | - |
Historique de carrière de Myron Wentz
Anciens postes connus de Myron Wentz
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IMMUNOSYN CORP | Director/Board Member | 14/03/2008 | 20/03/2009 |
Gull Laboratories, Inc.
 Gull Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Meridian Bioscience, Inc., Gull Laboratories, Inc. is a private company that specializes in surgical and medical instruments as well as drugs. The company is based in Salt Lake City, UT. The company was founded by Myron W. Wentz. Gull Laboratories was acquired by Meridian Bioscience, Inc. from Fresenius SE & Co. KGaA on November 05, 1998 for $18.04 million. | Chairman | 01/01/1974 | 01/01/1998 |
| Founder | 01/01/1974 | 01/01/1998 | |
| Sanoviv SA de CV | Founder | 01/01/1998 | - |
Formation de Myron Wentz
| University of Utah | Doctorate Degree |
| North Central College | Undergraduate Degree |
| University of North Dakota | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Mexique | 2 |
Opérationnelle
| Founder | 3 |
| Director/Board Member | 2 |
| Chairman | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| USANA HEALTH SCIENCES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Gull Laboratories, Inc.
Gull Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Meridian Bioscience, Inc., Gull Laboratories, Inc. is a private company that specializes in surgical and medical instruments as well as drugs. The company is based in Salt Lake City, UT. The company was founded by Myron W. Wentz. Gull Laboratories was acquired by Meridian Bioscience, Inc. from Fresenius SE & Co. KGaA on November 05, 1998 for $18.04 million. | Health Technology |
Immunosyn Corp.
 Immunosyn Corp. BiotechnologyHealth Technology Immunosyn Corp. is a development stage company. It engages in the marketing, distribution, and sale of a biopharmaceutical drug product SF-1019, which is used for the treatment of various diseases and pathological conditions, including chronic inflammatory demyelinating polyneuropathy, diabetic neuropathy, and diabetic ulcers. The company was founded in August 2006 and is headquartered in San Diego, CA. | Health Technology |
| Sanoviv SA de CV |
- Bourse
- Insiders
- Myron Wentz
- Expérience
